# Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers

> **NCT03291899** · PHASE2 · TERMINATED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 13 (actual)

## Conditions studied

- Biliary Tract Cancer

## Interventions

- **COMBINATION_PRODUCT:** FOLFIRINOX

## Key facts

- **NCT ID:** NCT03291899
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-03
- **Primary completion:** 2023-02-09
- **Final completion:** 2023-02-09
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** poor accrual
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03291899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03291899, "Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03291899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*